Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The study will be conducted in two phases; an in-patient meal study phase (Phase I) and an
outpatient home study (Phase II). The two phase study design is chosen to enhance safety by
testing the Afrezza Closed-Loop (CL) system in controlled in-clinic setting under study staff
supervision before it could be investigated at the outpatient home setting. Phase II will not
begin without the establishment of safety in Phase I.